Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-11

Study Completion Date

2021-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The SPIRIT study is interventional, national, prospective, open, multicentric each patient being his/her own control.

It is conducted to assess the safety and performance of the Atalante exoskeleton system in patients presenting a non-traumatic acute-subacute hemiplegia. The primary endpoint is defined by the patient's ability to perform the 10 MWT with the Atalante system.

The study will include at least 12 patients and takes place in three french rehabilitation centers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Safety and Performance of the Atalante System With Patients With Lower Limb Paralysis

NCT04110561

Spinal Cord Injuries Paraplegia Paralysis, Lower Limbs +2 more

COMPLETED NA

Effect of the Atalante Exoskeleton on Standing and Walking in Individuals With Paraplegia: A Prospective Controlled-Environment Study in a Rehabilitation Context

NCT06941896

Paraplegia, Complete

COMPLETED NA

Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia

NCT06939634

Spinal Cord Injury Tetraplegia/Tetraparesis Paraplegia, Complete +2 more

COMPLETED

Multitissular Effect of Vertical Mobilization Using the Exoskeleton AtalanteTM in Neurological Chair- or Bed-bound Patients

NCT05506306

Neurologic Disorder

UNKNOWN

Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis

NCT06199284

ALS - Amyotrophic Lateral Sclerosis

SUSPENDED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Stroke, Acute Stroke, Subacute Robotics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-traumatic hemiplegia in post stroke acute subacute phase

Group Type OTHER

Use of the Atalante exoskeleton

Intervention Type DEVICE

A session includes a stand-up, walks over a distance of 10 meters, exercises with or without the assistance of the exoskeleton, U-turns and a sitting.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use of the Atalante exoskeleton

A session includes a stand-up, walks over a distance of 10 meters, exercises with or without the assistance of the exoskeleton, U-turns and a sitting.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with non-traumatic vascular hemiplegia in acute subacute phase (15 days to 6 months) hospitalized in rehabilitation center,
* Patients presenting a FAC score of 0, 1 or 2,
* Patient with ischemic or hemorrhagic stroke of which etiological evaluation is complete,
* Adult patient ≥18 years old,
* Patient able to verticalize on a daily basis and having a stabilized blood pressure,
* Patient with stable medical condition at the time of inclusion in the study (absence of infectious and cardiorespiratory events),
* Patient's height is at least 1m55,
* Lengths of patient's lower limb are in the following intervals:

* Thigh (distance gluteus maximus - patella): 56.8 and 64.8 cm,
* Distance between the ground and the joint space of the knee (to be measured while wearing the shoes the patient intends to wear with Atalante):

* 45.7-60.7 cm for patient with an ankle dorsiflexion ≥ 16°
* 45.7-57.7 cm for patient with an ankle dorsiflexion \> 13° et \< 16°
* 45.7-56.7 cm for patient with an ankle dorsiflexion \> 10° et ≤ 13°
* 45.7-55.7 cm for patient with an ankle dorsiflexion ≥ 0° et ≤ 10°
* Intertrochanteric distance lower or equal to 46.0 cm when seated,
* Maximum weight: 90 kg,
* Patient able to read and write French and who have signed an informed consent form.

Exclusion Criteria

* Ranges of motion below:

* Hip: 90° flexion, 5° extension, 17° abduction, 10° adduction, 10° medial rotation, 20° lateral rotation
* Knee: 5° extension, 110° flexion
* Ankle: 0° dorsiflexion, 9° plantar flexion, 18° inversion and eversion
* Patient whose joint centers cannot be aligned Atalante's system,
* Severe spasticity (greater than 3 on the modified Ashworth scale) of the adductor muscles, hamstrings, quadriceps and triceps surae
* Pregnant or lactating women,
* Medical history of osteoporotic fracture and/or disease or treatment responsible for a secondary osteoporosis,
* Patient with a cardiac contraindication to physical exertion,
* Evolutive intercurrent disease: venous thrombosis, hypotension,
* Patient unable to deliver his/her consent,
* Patient under legal protection,
* Patient participating at the same time in another study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No